Literature DB >> 30605051

An Invasive Hemolymphangioma of the Pancreas in a Young Woman.

Zhijun Zhang1,2, Qinghong Ke1,2, Weiliang Xia1,2, Xiuming Zhang3, Yan Shen1,2, Shusen Zheng1,2.   

Abstract

BACKGROUND: Hemolymphangioma is a rare benign tumor. To the best of our knowledge, there were only 10 reports of this tumor of the pancreas until March 2018. CASE REPORT: Here, we reported a large invasive hemolymphangioma of the pancreas in a young woman with a complaint of abdominal distension and an epigastric mass about 3 weeks. She was found to have a huge multilocular cystic tumor at the neck and body of pancreas on computed tomography. She was eventually diagnosed with hemolymphangioma of the pancreas after operation. After 2 years of follow-up, there was no signs of recurrence.
CONCLUSION: From our case and literature, we can conclude that hemolymphangioma of the pancreas is uncommon benign tumor, and it is hard to make an accurate diagnosis preoperatively. Radical surgical resection should be performed whenever possible. The prognosis of this disease seems good. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.

Entities:  

Keywords:  Hemolymphangioma; benign tumor; cystic neoplasm; differential diagnosis; pancreas; surgery.

Mesh:

Year:  2018        PMID: 30605051     DOI: 10.2174/1386207322666190103110747

Source DB:  PubMed          Journal:  Comb Chem High Throughput Screen        ISSN: 1386-2073            Impact factor:   1.339


  2 in total

1.  Giant Hepatic Hemolymphangioma With Peritoneal Effusion in Children: A Case Report and Literature Review.

Authors:  Yufeng Li; Lei Ta; Yuan Xu; Jianli Liu
Journal:  Front Pediatr       Date:  2022-02-18       Impact factor: 3.418

2.  Hemolymphangioma of the transverse mesocolon: a case report and literature review.

Authors:  Xiangyang Li; Yuting Zhang; Huaiquan Sun; Quannian Shao; Shuze Zhang; Fan Li; Zuoyi Jiao
Journal:  Transl Cancer Res       Date:  2021-08       Impact factor: 1.241

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.